Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Varenicline Pregnancy Cohort Study Protocol Chantix(Registered)/Champix(Registered) (Varenicline Tartrate)

NCT01290445 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01290445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01290445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Varenicline Pregnancy Cohort Study Protocol Chantix(Registered)/Champix(Registered) (Varenicline Tartrate)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
September 13, 2007
Completion date
May 1, 2016
Enrollment
885,185 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malformations